A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 45/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2534197
Methods of treating cancer and/or reducing or inhibiting tumor growth in a subject in need thereof, comprising administering pharmaceutical composition comprising a vascular endothelial cell growth factor (VEGF) inhibitor or trap, such as the VEGF trap of SEQ ID NO: 1 or SEQ ID NO:3, in combination with radiation therapy, including ionization radiation and/or a therapeutic radiopharmaceutical.
La présente invention se rapporte à des méthodes permettant de traiter un cancer et/ou de réduire ou d'inhiber la croissance tumorale chez un sujet concerné. Lesdites méthodes consistent à administrer une composition pharmaceutique contenant un inhibiteur ou un piège des facteurs de croissance des cellules endothéliales vasculaires (VEGF), tel que le piège des VEGF de SEQ ID NO:1 ou SEQ ID NO:3, et d'effectuer en parallèle une radiothérapie, laquelle consiste en un rayonnement par ionisation et/ou un produit radiopharmaceutique.
Burd Randy
Dicker Adam P.
Holash Jocelyn
Wachsberger Phyllis R.
Yancopoulos George
Blake Cassels & Graydon Llp
Regeneron Pharmaceuticals Inc.
Thomas Jefferson University
LandOfFree
Use of a vegf antagonist in combination with radiation therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a vegf antagonist in combination with radiation therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a vegf antagonist in combination with radiation therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1933062